Item 2.02 Results of Operations and Financial Conditions.




On August 3, 2020, STERIS plc (the "Company") issued a press release announcing
financial results for the three month period ended June 30, 2020. A copy of this
press release is attached hereto as Exhibit 99.1.
The information contained in this Item 2.02 of this Current Report on Form 8-K,
including Exhibit 99.1 attached hereto, is being furnished to the Securities and
Exchange Commission and shall not be deemed to be "filed" for purposes of
Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the
liabilities of that Section. Furthermore, the information contained in this Item
2.02 of this Current Report on Form 8-K shall not be deemed to be incorporated
by reference into any registration statement or other document filed pursuant to
the Securities Act of 1933.
Item 5.02   Departure of Directors or Certain Officers; Election of Directors;
            Appointment of Certain Officers; Compensatory Arrangements of
            Certain Officers


The Company's Board of Directors increased the number of Directors currently
serving from eight to nine members on July 28, 2020, and appointed Christopher
Holland to serve as Director effective as of that date.
Mr. Holland most recently served as Senior Vice President and Chief Financial
Officer at C.R. Bard prior to its 2017 acquisition by Becton, Dickinson and
Company. Previously Mr. Holland served as Senior Vice President of Finance and
Treasurer at Aramark, and spent fifteen years at JPMorgan Chase & Co.,
ultimately in the role of Vice President and Medical Device Sector Head,
Investment Banking. Mr. Holland also serves on the Board of Jabil Inc. and is a
member of its Audit and Cybersecurity Committees.
Mr. Holland will serve on the Audit and the Compensation and Organization
Development Committees of the Company's Board.
Mr. Holland will receive the $290,000 annual retainer fee payable to all Company
Directors (other than the Chairman) later in August. This fee will be payable
partially in cash and partially in career restricted stock units.
Item 5.07 Submission of Matters to a Vote of Security Holders.

At the Company's 2020 Annual General Meeting of Shareholders ("Meeting") held on July 28, 2020, shareholders voted on the matters specified below, with the final voting results as specified. According to the certified list of shareholders, there were 84,951,399 Ordinary Shares of the Company outstanding and entitled to vote at the Meeting. There were present at the Meeting, in person or by proxy, the holders of 77,000,235 Ordinary Shares or 90.64% of the outstanding Ordinary Shares of the Company, constituting a quorum. 1. The nominees named below were re-elected to the Board of Directors, each for a


    one-year term, and the results of the vote were as follows:


         Nominee            Votes for    Votes against    Abstentions    Broker non-votes
Richard C. Breeden         71,608,671        2,671,457         91,835           2,628,272
Cynthia L. Feldmann        71,572,080        2,623,058        176,825           2,628,272
Dr. Jacqueline B. Kosecoff 70,065,987        4,204,647        101,329           2,628,272
David B. Lewis             72,829,020        1,379,813        163,130           2,628,272
Walter M Rosebrough, Jr.   73,358,621          810,340        203,002           2,628,272
Dr. Nirav R. Shah          74,075,199          125,741        171,023           2,628,272
Dr. Mohsen M. Sohi         71,188,170        3,077,866        105,927           2,628,272
Dr. Richard M. Steeves     71,928,068        2,252,492        191,403           2,628,272

2. The results of a proposal to ratify the appointment of Ernst & Young LLP as the

Company's independent registered public accounting firm for the year ending

March 31, 2021 were as follows:




Votes for     73,609,583
Votes against  3,324,252
Abstentions       66,400

--------------------------------------------------------------------------------




3.   The results of a proposal to appoint Ernst & Young Chartered Accountants as
    the Company's statutory auditor under Irish law to hold office until the
    conclusion of the Company's next Annual General Meeting were as follows:


Votes for     73,961,863
Votes against  2,977,159
Abstentions       61,213


4.  The results of a proposal to authorize the Directors of the Company or the
    Audit Committee to determine the remuneration of Ernst & Young Chartered
    Accountants as the Company's statutory auditor under Irish law were as follows:


Votes for     76,765,742
Votes against    179,776
Abstentions       54,717


5.  The results of a proposal to approve, on a non-binding advisory basis, the
    compensation of the Company's named executive officers as disclosed pursuant to
    the disclosure rules of the Securities and Exchange Commission, including the
    Compensation Discussion and Analysis and the tabular and narrative disclosure
    contained in the Company's proxy statement dated June 12, 2020, were as
    follows:


Votes for        71,550,687
Votes against     2,713,406
Abstentions         107,870
Broker non-votes  2,628,272

Item 9.01 Financial Statements and Exhibits.




(d) Exhibits:

 Exhibit
   No.                                     Description
   99.1          Press Release issued by STERIS plc on August 3, 2020 announcing
               financial results for the three month period ended June 30, 2020
               and appointment of new Director.
   104         Cover Page Interactive Data File (embedded within the Inline XBRL
               document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses